A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus

Authors:
  • RCR. Chang
    R. Chang
  • VLV. Lotti
    V. Lotti
  • RMR. Monaghan
    R. Monaghan
  • JBJ Birnbaum
    J Birnbaum
  • ESE. Stapley
    E. Stapley
  • MGM. Goetz
    M. Goetz
  • GAG Albers-Schonberg
    G Albers-Schonberg
  • APA. Patchett
    A. Patchett
  • JLJ. Liesch
    J. Liesch
  • OHO. Hensens
    O. Hensens
  • AEAl. Et
    Al. Et

Abstract
A new, competitive, nonpeptide cholecystokinin (CCK) antagonist, asperlicin, was isolated from the fungus Aspergillus alliaceus. The compound has 300 to 400 times the affinity for pancreatic, ileal, and gallbladder CCK receptors than proglumide, a standard agent of this class. Moreover, asperlicin is highly selective for peripheral CCK receptors relative to brain CCK and gastrin receptors. Since asperlicin also exhibits long-lasting CCK antagonist activity in vivo, it should provide a valuable tool for investigating the physiological and pharmacological actions of CCK.

This publication has 10 references indexed in Scilit: